Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund

We’re excited to announce a major milestone in Sequentia Biotech’s journey: we’ve successfully secured a €10 million Series A investment, led by Seventure Partners and co-invested by the EIC Fund.

This funding marks a significant step forward in our mission to deliver cutting-edge bioinformatics technologies to the market. It will primarily support the development and expansion of MICK®, our flagship platform, enhancing its capabilities and making it accessible to a broader global audience.

With this new capital, we are set to accelerate our go-to-market strategy, bringing our advanced bioinformatics solutions to sectors where high-quality, reliable data is essential for breakthroughs—especially in fields such as biomedicine, agriculture, and industrial biotechnology.

The investment enables us to deepen our impact in precision diagnostics and treatments, contributing to the transformation of healthcare and the advancement of omics science. We’re proud to play a role in building a future where innovation leads to more sustainable solutions and improved quality of life.

We are deeply grateful to Seventure Partners and the EIC Fund for their support.

Together, we’re driving the future of bioinformatics—and bringing omics to life.

For more details visit: https://www.businesswire.com/news